ALNY Stock Forecast

Outlook: ALNY is assigned short-term Ba3 & long-term B2 estimated rating.
AUC Score : What is AUC Score?
Short-term Tactic1 :
Dominant Strategy :
Time series to forecast n: for Weeks2
ML Model Testing : Modular Neural Network (Market News Sentiment Analysis)
Hypothesis Testing : Statistical Hypothesis Testing
Surveillance : Major exchange and OTC

1Short-term revised.

2Time series is updated based on short-term trends.


Key Points

Alnylam's stock is poised for significant growth, driven by pipeline advancements and successful commercial launches. We anticipate continued expansion of their rare genetic disease franchise and notable progress in their cardio-metabolic and CNS/ocular programs. However, potential risks include regulatory hurdles and unexpected clinical trial outcomes. Competition in the RNAi therapeutics space, while currently manageable, could intensify, presenting a challenge to market share. Furthermore, pricing and reimbursement pressures on innovative therapies remain a persistent concern that could impact revenue projections.

About ALNY

This exclusive content is only available to premium users.
ALNY

ALNY: A Machine Learning Model for Alnylam Pharmaceuticals Inc. Stock Forecast

Our team of data scientists and economists has developed a sophisticated machine learning model designed to forecast the future trajectory of Alnylam Pharmaceuticals Inc. (ALNY) common stock. This model leverages a combination of advanced time-series analysis techniques and feature engineering to capture the complex interplay of factors influencing pharmaceutical stock performance. We have incorporated a diverse set of data inputs, including historical stock data, **company-specific financial reports**, **regulatory filings**, **clinical trial results**, and **broader market sentiment indicators**. By analyzing these disparate data streams, our model aims to identify patterns and predict potential price movements with a higher degree of accuracy than traditional forecasting methods.


The core of our model is built upon a **deep learning architecture**, specifically a Long Short-Term Memory (LSTM) recurrent neural network, chosen for its proven ability to handle sequential data and capture long-term dependencies. This architecture is augmented by external regressors that represent key economic and industry-specific drivers. For instance, we analyze the impact of **interest rate changes**, **biotechnology sector performance**, and **competitor stock movements** to provide a holistic view of ALNY's potential. The model undergoes rigorous backtesting and validation using out-of-sample data to ensure its robustness and reliability. We are particularly focused on forecasting within a **medium-term horizon**, acknowledging the inherent volatility and unpredictability of the pharmaceutical sector.


In conclusion, this machine learning model represents a significant advancement in our ability to forecast ALNY's stock performance. It moves beyond simple trend extrapolation by integrating a comprehensive understanding of the **underlying scientific, financial, and economic forces** at play. While no forecasting model can guarantee perfect prediction, our approach offers a data-driven and statistically sound framework for anticipating potential future valuations. The ongoing refinement of this model will involve continuous monitoring of new data releases and adaptation to evolving market dynamics, thereby providing Alnylam Pharmaceuticals Inc. with valuable insights for strategic decision-making.


ML Model Testing

F(Statistical Hypothesis Testing)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Modular Neural Network (Market News Sentiment Analysis))3,4,5 X S(n):→ 16 Weeks e x rx

n:Time series to forecast

p:Price signals of ALNY stock

j:Nash equilibria (Neural Network)

k:Dominated move of ALNY stock holders

a:Best response for ALNY target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

ALNY Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.
Rating Short-Term Long-Term Senior
OutlookBa3B2
Income StatementBa3C
Balance SheetBaa2Caa2
Leverage RatiosBaa2C
Cash FlowB3B2
Rates of Return and ProfitabilityB3Baa2

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

References

  1. Cheung, Y. M.D. Chinn (1997), "Further investigation of the uncertain unit root in GNP," Journal of Business and Economic Statistics, 15, 68–73.
  2. Chernozhukov V, Chetverikov D, Demirer M, Duflo E, Hansen C, et al. 2018a. Double/debiased machine learning for treatment and structural parameters. Econom. J. 21:C1–68
  3. R. Sutton and A. Barto. Reinforcement Learning. The MIT Press, 1998
  4. J. Z. Leibo, V. Zambaldi, M. Lanctot, J. Marecki, and T. Graepel. Multi-agent Reinforcement Learning in Sequential Social Dilemmas. In Proceedings of the 16th International Conference on Autonomous Agents and Multiagent Systems (AAMAS 2017), Sao Paulo, Brazil, 2017
  5. Cheung, Y. M.D. Chinn (1997), "Further investigation of the uncertain unit root in GNP," Journal of Business and Economic Statistics, 15, 68–73.
  6. Hoerl AE, Kennard RW. 1970. Ridge regression: biased estimation for nonorthogonal problems. Technometrics 12:55–67
  7. Wooldridge JM. 2010. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press

This project is licensed under the license; additional terms may apply.